The qualifying criteria of this session is participants must be a global or regional head of Business Development, Alliances or M&A of a global pharmaceutical company.
A unique, powerful and valuable space in which the biggest deal-makers from global pharma share their experiences, discuss their collective challenges and look ahead at future developments and actionable outcomes.
Like-minded executives are joined by 2 appropriate and value-matched industry stakeholders and partners to provide expertise, experience and best practice on strategic areas of focus. Case studies will also be delivered by a number of executives who have enjoyed success or navigated key challenges in their pursuit of company growth.
Strategic topics include, but not restricted to, market drivers, industry collaboration, cross-border transactions, business resilience, deal making / partnerships and sector growth.
A pre-registration, invite-only, Chatham House Rule forum hosted virtually where all participants are active discussants.
Attendance is free, however executives must satisfy the key criteria points outlined during registration.
Date: Thursday 24 June 2021
Timings:10:00AM - 12:00PM EDT / 09:00 - 11:00PM CST / 7:00AM - 9.00AM PDT and across UK & Europe at 15.00 - 17.00 BST / 16.00 - 18.00 CET
Pre-event - Benchmarking survey
10mins - Participant intro's and sharing of benchmarking results
20mins - Co-host case study 1 + Q&A
10mins - Peer case study 1
10mins - Guest speaker
20mins - Co-host case study 2 + Q&A
10mins - Peer case study 2
10mins - Peer-to-peer interactive poll
30mins - General discussion
For sponsorship enquiries contact: